Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Peel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry|August 16, 2017
Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activityAnthony J Brockway, Oleg A Volkov, Casey C Cosner, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated CandidiasisStephen A Wring, Ryan Randolph, SeongHee Park, et al.
Journal of Hepatology|November 29, 2016
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Koichi Watashi, Kento Fukano, et al.
ACS Infectious Diseases|March 29, 2017
Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based AssayOleg A Volkov, Casey C Cosner, Anthony J Brockway, et al.
European Journal of Pharmacology|August 31, 2020
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseasesMaryanne Covington, Xin He, Monika Scuron, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2015
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafunginJames M Apgar, Robert R Wilkening, Mark L Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
MK-5204: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Anais Da Academia Brasileira De Ciencias|June 2, 2021
Baryon Acoustic Oscillations from Integrated Neutral Gas Observations: an instrument to observe the 21cm hydrogen line in the redshift range 0.13 < z < 0.45 - status updateCarlos A Wuensche, Elcio Abdalla, Filipe Abdalla, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Bioorganic & Medicinal Chemistry|August 16, 2017
Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activityAnthony J Brockway, Oleg A Volkov, Casey C Cosner, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated CandidiasisStephen A Wring, Ryan Randolph, SeongHee Park, et al.
Journal of Hepatology|November 29, 2016
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Koichi Watashi, Kento Fukano, et al.
ACS Infectious Diseases|March 29, 2017
Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based AssayOleg A Volkov, Casey C Cosner, Anthony J Brockway, et al.
European Journal of Pharmacology|August 31, 2020
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseasesMaryanne Covington, Xin He, Monika Scuron, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2015
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafunginJames M Apgar, Robert R Wilkening, Mark L Greenlee, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
MK-5204: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Anais Da Academia Brasileira De Ciencias|June 2, 2021
Baryon Acoustic Oscillations from Integrated Neutral Gas Observations: an instrument to observe the 21cm hydrogen line in the redshift range 0.13 < z < 0.45 - status updateCarlos A Wuensche, Elcio Abdalla, Filipe Abdalla, et al.
Pageof 2